ATE366726T1 - Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole - Google Patents
Stereoselektive synthese bestimmter trifluormethylsubstituierter alkoholeInfo
- Publication number
- ATE366726T1 ATE366726T1 AT04789408T AT04789408T ATE366726T1 AT E366726 T1 ATE366726 T1 AT E366726T1 AT 04789408 T AT04789408 T AT 04789408T AT 04789408 T AT04789408 T AT 04789408T AT E366726 T1 ATE366726 T1 AT E366726T1
- Authority
- AT
- Austria
- Prior art keywords
- stereoselective synthesis
- trifluoromethyl
- substituted alcohols
- aryl
- alkyl
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 230000000707 stereoselective effect Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 150000001298 alcohols Chemical class 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 abstract 1
- 125000006730 (C2-C5) alkynyl group Chemical group 0.000 abstract 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005133 alkynyloxy group Chemical group 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- -1 chloro, hydroxy Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000003003 spiro group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51174403P | 2003-10-16 | 2003-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366726T1 true ATE366726T1 (de) | 2007-08-15 |
Family
ID=34520036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04789408T ATE366726T1 (de) | 2003-10-16 | 2004-09-30 | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7507843B2 (de) |
| EP (1) | EP1675839B1 (de) |
| JP (1) | JP4468369B2 (de) |
| AT (1) | ATE366726T1 (de) |
| CA (1) | CA2542741A1 (de) |
| DE (1) | DE602004007539T2 (de) |
| ES (1) | ES2290769T3 (de) |
| WO (1) | WO2005040145A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4324480B2 (ja) * | 2002-03-26 | 2009-09-02 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメティクス、その製法、医薬組成物、及び使用 |
| HRP20050185A2 (en) * | 2002-08-29 | 2006-05-31 | Boehringer Ingelheim Pharmaceuticals Inc. | -3 (sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| US7795272B2 (en) * | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| US7635711B2 (en) * | 2004-12-27 | 2009-12-22 | Boehringer-Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| AR060536A1 (es) | 2006-04-20 | 2008-06-25 | Glaxo Group Ltd | Agonista del receptor de glucocorticoides y composiciones farmaceuticas |
| JP2010512331A (ja) * | 2006-12-06 | 2010-04-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | グルココルチコイド模倣薬、それらの製造方法、医薬組成物、及びこれらの使用 |
| DK2300472T3 (da) * | 2008-06-06 | 2012-04-10 | Boehringer Ingelheim Int | Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf |
| US20110130578A1 (en) * | 2009-06-03 | 2011-06-02 | Boehringer Ingelheim International Gmbh | Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| JP5472217B2 (ja) | 2011-06-29 | 2014-04-16 | 信越化学工業株式会社 | 2,2−ビス(フルオロアルキル)オキシラン類を用いた光酸発生剤の製造方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8402755A (nl) | 1983-09-22 | 1985-04-16 | Sandoz Ag | Azool-derivaten, werkwijze voor het bereiden daarvan, preparaten die ze bevatten, en toepassing daarvan. |
| GB8406000D0 (en) | 1984-03-07 | 1984-04-11 | Ici Plc | Olefine derivatives |
| GB8617653D0 (en) | 1986-07-18 | 1986-08-28 | Ici Plc | Amide derivatives |
| GB8617652D0 (en) * | 1986-07-18 | 1986-08-28 | Ici Plc | Acylanilide derivatives |
| US5039691A (en) * | 1989-06-08 | 1991-08-13 | Marion Merrell Dow Inc. | 5-(1-(imidazol)methyl)-3,3-disubstituted-2(3H)furanone derivatives |
| EP1043326A1 (de) | 1994-12-22 | 2000-10-11 | Ligand Pharmaceuticals Incorporated | Steroidrezeptor-Modulator Verbindungen und Methoden |
| US6066738A (en) | 1996-01-30 | 2000-05-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| DE19723722A1 (de) | 1997-05-30 | 1998-12-10 | Schering Ag | Nichtsteroidale Gestagene |
| US6506766B1 (en) | 1998-02-13 | 2003-01-14 | Abbott Laboratories | Glucocortiocoid-selective antinflammatory agents |
| WO1999041256A1 (en) | 1998-02-13 | 1999-08-19 | Abbott Laboratories | Glucocorticoid-selective anti-inflammatory agents |
| US6187918B1 (en) * | 1999-03-15 | 2001-02-13 | Dupont Pharmaceuticals Company | Catalysts for asymmetric addition of organozinc reagents to aldehydes and method for preparation |
| DE19856475A1 (de) | 1998-11-27 | 2000-05-31 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| CA2372173A1 (en) | 1999-04-30 | 2000-11-09 | Pfizer Products Inc. | Glucocorticoid receptor modulators |
| US6436986B1 (en) * | 1999-09-01 | 2002-08-20 | Abbott Laboratories | Glucocorticoid receptor antagonists for treatment of diabetes |
| US6329534B1 (en) * | 1999-09-01 | 2001-12-11 | Abbott Laboratories | Glucocorticoid receptor antagonists for treatment of diabetes |
| DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| US6583180B2 (en) * | 2001-02-14 | 2003-06-24 | Abbott Laboratories | Glucocorticoid receptor modulators |
| CA2438480C (en) | 2001-02-14 | 2011-05-03 | Abbott Laboratories | Glucocorticoid receptor modulators |
| ES2276038T3 (es) | 2002-01-14 | 2007-06-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Mimeticos de glucocorticoides, metodos para su obtencion, formulaciones farmaceuticas que los contienen y usos de los mismos. |
| JP2005521717A (ja) * | 2002-03-26 | 2005-07-21 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用 |
| DE10215316C1 (de) * | 2002-04-02 | 2003-12-18 | Schering Ag | Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer |
| US6897224B2 (en) * | 2002-04-02 | 2005-05-24 | Schering Ag | Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| US7186864B2 (en) * | 2002-05-29 | 2007-03-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| US7074806B2 (en) * | 2002-06-06 | 2006-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| AU2003259747A1 (en) * | 2002-08-21 | 2004-03-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| HRP20050185A2 (en) * | 2002-08-29 | 2006-05-31 | Boehringer Ingelheim Pharmaceuticals Inc. | -3 (sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| CA2512257A1 (en) * | 2003-01-03 | 2004-07-29 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| US20040224992A1 (en) * | 2003-02-27 | 2004-11-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
-
2004
- 2004-09-30 DE DE602004007539T patent/DE602004007539T2/de not_active Expired - Lifetime
- 2004-09-30 ES ES04789408T patent/ES2290769T3/es not_active Expired - Lifetime
- 2004-09-30 EP EP04789408A patent/EP1675839B1/de not_active Expired - Lifetime
- 2004-09-30 WO PCT/US2004/032257 patent/WO2005040145A1/en not_active Ceased
- 2004-09-30 CA CA002542741A patent/CA2542741A1/en not_active Abandoned
- 2004-09-30 US US10/955,165 patent/US7507843B2/en not_active Expired - Lifetime
- 2004-09-30 JP JP2006535528A patent/JP4468369B2/ja not_active Expired - Lifetime
- 2004-09-30 AT AT04789408T patent/ATE366726T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005040145A1 (en) | 2005-05-06 |
| DE602004007539T2 (de) | 2007-10-25 |
| US20050131241A1 (en) | 2005-06-16 |
| EP1675839B1 (de) | 2007-07-11 |
| JP2007509069A (ja) | 2007-04-12 |
| JP4468369B2 (ja) | 2010-05-26 |
| DE602004007539D1 (de) | 2007-08-23 |
| CA2542741A1 (en) | 2005-05-06 |
| EP1675839A1 (de) | 2006-07-05 |
| ES2290769T3 (es) | 2008-02-16 |
| US7507843B2 (en) | 2009-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW359670B (en) | Process for producing quinazolin-4-one derivatives | |
| WO2007149448A3 (en) | Pyrazinones as cellular proliferation inhibitors | |
| MX2009005449A (es) | Compuesto heteromonociclico y uso del mismo. | |
| CO6220952A2 (es) | Nuevos derivados de 3-([1,2,4]triazolo[4,3-a]piridin-7-il)benzamida | |
| EA201170196A1 (ru) | Производные бензазепинов и их применение в качестве h3 гистаминовых антагонистов | |
| HRP20080541T3 (en) | Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases | |
| CO5580779A2 (es) | Pirimidinonas como receptor 1 de la hormona concentradora de la melanina | |
| RU2009139920A (ru) | Изоксазолиновые соединения и их применение в борьбе с вредителями | |
| NZ599040A (en) | 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases | |
| BRPI0515571A (pt) | agonistas de receptor de trombopoetina | |
| ATE366726T1 (de) | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole | |
| AU1253002A (en) | Imidazo-triazine derivatives as ligands for gaba receptors | |
| MY172034A (en) | Intermediate for producing bicyclic ?-amino acid derivative | |
| TNSN08372A1 (en) | Heterocyclic amides for use as pharmaceuticals | |
| ES2192235T3 (es) | Derivados de 4-pirimidinil- o 4-piracinil-piperacinil-fenil-oxazolidinona, su preparacion y uso como agentes antibacterianos. | |
| TW200745034A (en) | New compounds | |
| DE602007012875D1 (de) | Benzimidazole und ihre verwendung zur behandlung von diabetes | |
| NZ581438A (en) | Kallikrein 7 modulators | |
| PH12012502363A1 (en) | Process for the preparation of dihydropyrrole derivatives | |
| ES2578628T3 (es) | Compuestos de L-dihidro-2-oxoquinolina como ligandos del receptor de 5-HT4 | |
| NZ596653A (en) | Total synthesis of salinosporamide a and analogs thereof | |
| MX2009008772A (es) | Derivado piridil-triazolopirimidina o su sal, pesticida que lo contiene y proceso para su produccion. | |
| CY1116388T1 (el) | 5-(φαινυλο/πυριδινυλο-αιθινυλο)-2-πυριδινο/2-πυριμιδινο-καρβοξαμιδια ως mglur5 ρυθμιστες | |
| MX2024008276A (es) | Metodos para sintetizar compuestos de 1h-furo[3,2-b]imidazo[4,5-d] piridina. | |
| CO5700763A2 (es) | Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra |